Literature DB >> 27892628

Association between FOXP3 gene polymorphisms and risk of differentiated thyroid cancer in Chinese Han population.

Weichao Jiang1, Lei Zheng1,2, Lijuan Xu1,3, Yang Zhang1, Xingxin Liu1, Lihua Hu1, Xiaobei Wang1.   

Abstract

BACKGROUND: Foxp3 plays important roles in autoimmune and inflammatory diseases as well as human malignancies. This study aimed to investigate the association between Foxp3 gene polymorphisms and the susceptibility to differentiated thyroid cancers (DTC).
METHODS: Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 350 DTC patients and 306 healthy controls. FOXP3 relative expression was measured by real-time quantitative PCR (qRT-PCR).
RESULTS: AA/AC genotype of Foxp3-rs3761548 was associated with a higher risk of DTC. The frequency of Foxp3-rs2280883 CC/CT genotype was lower in DTC patients. Besides, the AA/AC genotype of rs3761548 was more frequent in female DTC than male DTC. The association between two single nucleotide polymorphisms (SNPs) and clinical characteristics of DTC was further analyzed. We found that rs3761548 AA/AC genotype was more frequent in severe DTC patients (tumor diameter >1 cm) compared with the relative tender DTC patients (tumor diameter <1 cm). On the contrast, the frequency of rs2280883 CC/CT genotype was lower in severe DTC patients. In addition, the Foxp3 relative expression in DTC with AA/AC genotype of rs3761548 was higher than that of DTC with CC genotype.
CONCLUSION: Our findings suggested that Foxp3 polymorphisms were associated with the risk of DTC in Chinese Han population.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  FOXP3; differentiated thyroid cancer; single nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27892628      PMCID: PMC6817120          DOI: 10.1002/jcla.22104

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  25 in total

Review 1.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  Foxp3 promoter polymorphism (rs3761548) in breast cancer progression: a study from India.

Authors:  Parveen Jahan; V R Vinish Ramachander; G Maruthi; S Nalini; K Prasanna Latha; T S R Murthy
Journal:  Tumour Biol       Date:  2013-12-13

3.  The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.

Authors:  Elena Bonora; Cosmeri Rizzato; Chiara Diquigiovanni; Tiphaine Oudot-Mellakh; Daniele Campa; Manuela Vargiolu; Mickaël Guedj; James D McKay; Giovanni Romeo; Federico Canzian; Fabienne Lesueur
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

4.  Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.

Authors:  Gisella Figlioli; Aleksandra Köhler; Bowang Chen; Rossella Elisei; Cristina Romei; Monica Cipollini; Alfonso Cristaudo; Franco Bambi; Elisa Paolicchi; Per Hoffmann; Stefan Herms; Michał Kalemba; Dorota Kula; Susana Pastor; Ricard Marcos; Antonia Velázquez; Barbara Jarząb; Stefano Landi; Kari Hemminki; Asta Försti; Federica Gemignani
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

5.  Association of FoxP3 rs3761548 polymorphism with susceptibility to colorectal cancer in the Chinese population.

Authors:  Lei Chen; Qiming Yu; Bixia Liu; Liming Zhu
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

6.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  Expression of FoxP3 protein plays a key role in thyroid tumors in children.

Authors:  Łukasz Szylberg; Magdalena Bodnar; Jerzy Harasymczuk; Andrzej Marszalek
Journal:  Fetal Pediatr Pathol       Date:  2013-12-13       Impact factor: 0.958

8.  FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment.

Authors:  Clara Ugolini; Rossella Elisei; Agnese Proietti; Serena Pelliccioni; Cristiana Lupi; Nicla Borrelli; David Viola; Pietro Leocata; Paolo Vitti; Paolo Miccoli; Antonio Toniolo; Fulvio Basolo
Journal:  Thyroid       Date:  2013-09-26       Impact factor: 6.568

Review 9.  Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases.

Authors:  Julie Massayo Maeda Oda; Bruna Karina Banin Hirata; Roberta Losi Guembarovski; Maria Angelica Ehara Watanabe
Journal:  J Genet       Date:  2013-04       Impact factor: 1.166

10.  FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China.

Authors:  YanHui Chen; HengHui Zhang; WeiJia Liao; JinXue Zhou; GaiXia He; XingWang Xie; Ran Fei; LiLing Qin; Lai Wei; HongSong Chen
Journal:  J Exp Clin Cancer Res       Date:  2013-06-10
View more
  3 in total

1.  Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women.

Authors:  Tian Tian; Meng Wang; Yi Zheng; Tielin Yang; Wenge Zhu; Hongtao Li; Shuai Lin; Kang Liu; Peng Xu; Yujiao Deng; Linghui Zhou; Zhijun Dai
Journal:  Cancer Manag Res       Date:  2018-04-26       Impact factor: 3.989

2.  FOXP3 and CTLA-4 genetic variants' influence on the susceptibility and clinical course of basal cell carcinoma.

Authors:  Martyna Sławińska; Monika Zabłotna; Roman J Nowicki; Michał Sobjanek
Journal:  Postepy Dermatol Alergol       Date:  2020-02-27       Impact factor: 1.837

Review 3.  Functional Foxp3 polymorphisms and the susceptibility to cancer: An update meta-analysis.

Authors:  ZhenYun Cheng; Yan Guo; Liang Ming
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.